Faculty

Our section has 9 physicians focused on adult neuroimmunology and 3 physicians focused on pediatric neuroimmunology. In addition to clinical care, the faculty have broad interests in education, clinical research, basic research, and quality improvement. All are faculty members at the University of Colorado School of Medicine and see patients at the Rocky Mountain MS Center at the University of Colorado Hospital. Our faculty also see patients at Children's Hospital Colorado, Denver Health Medical Center, and the Rocky Mountain Regional VA Medical Center. Our section also has 2 nurse practitioners focused on patient care at the Rocky Mountain MS Center at the University of Colorado Hospital.

Physicians

Enrique Alvarez, MD/PhD is head of the Neuroimmunology Section and Medical Director of the Rocky Mountain MS Center. He is a Professor of Neurology and also serves as Vice Chair of Clinical Research for the Department of Neurology. Dr. Alvarez is a graduate of the Medical Scientist Training program at the University of Colorado School of Medicine. He completed his neurology residency and neuroimmunology fellowship at Washington University in St. Louis where he also received a master's degree in clinical investigation. Dr. Alvarez’s research interests and projects include clinical trials, use of real-world data to evaluate therapeutics, and fluid and imaging biomarkers for multiple sclerosis.

CU Profile

Google Scholar

Jeffrey Bennett, MD/PhD is a Professor of Neurology and Ophthalmology and Vice Chair of Basic Research for the Department of Neurology. He is a member of the Immunology and Neuroscience programs and holds the Gertrude Gilden Professorship. Dr. Bennett received his undergraduate degrees in biochemistry and philosophy at Case Western Reserve University. He then received his MD and PhD at Stanford University. Dr. Bennett directs research programs on optic neuritis, demyelinating disorders, and ocular inflammatory diseases. He also maintains active specialty practices in neuro-ophthalmology and demyelinating diseases including MS, NMOSD, and MOGAD.

As a clinician-scientist, Dr. Bennett is devoted to understanding the effects of autoimmune demyelination on the nervous system and using this knowledge to transform the care of affected individuals. In the clinic, Dr. Bennett directs clinical trials on new therapies for optic neuritis and neuromyelitis optica. In the laboratory, Dr. Bennett is working to identify the targets of the immune response in neuromyelitis optica and multiple sclerosis and is working to understand the mechanisms by which these disorders cause damage to the nervous system. His laboratory uses multiple experimental methods to evaluate the targets and action of antibodies derived from immune cells in the spinal fluid of neuromyelitis optica and multiple sclerosis patients, and employs state-of-the art techniques to establish the role of these antibodies in causing disease.

CU Profile

Google Scholar

John Corboy, MD is a Professor Emeritus and continues clinical work by regularly supervising fellow continuity clinics.

Dr. Corboy completed his undergraduate, medical school, and residency training in neurology at the University of Pennsylvania. He then completed his postdoctoral fellowship in neurovirology at the John Hopkins University School of Medicine. He specialized in multiple sclerosis and neurovirology at the University of Minnesota before moving to Colorado in 1994. In 1997, he founded the University of Colorado Multiple Sclerosis Center and built it into a multidisciplinary group offering state-of-the-art care and research to patients with MS and related disorders. He transitioned to emeritus status in 2024.

Dr. Corboy is a fellow of the American Academy of Neurology and is an elected member of the American Neurological Association and AOA. His main areas of interest are diagnostic issues and clinical therapeutics in multiple sclerosis. He was the first editor of Neurology: Clinical Practice and is currently an Associate Editor for Annals of Neurology. He has a longstanding interest in graduate medical education.

CU Profile

Robert Gross, MD/MSCR is an Associate Professor of Neurology and Program Director for the Neuroimmunology Fellowship Program. Dr. Gross attended college at Columbia University and medical school at New York University. He completed internship in internal medicine and neurology residency at Brown University before fellowship in neuroimmunology and a master's degree in clinical research at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mt. Sinai. Dr. Gross sees patients with multiple sclerosis and related disorders of the central nervous system. He divides his time between patient care, teaching, and clinical research. Research interests include the identification of biomarkers associated with treatment response in multiple sclerosis and the establishment of prospective databases to aid in prognostication.

CU Profile

Ryan Kammeyer, MD/MS is an Assistant Professor of Neurology and Pediatrics. Dr. Kammeyer completed medical school at Indiana University and child neurology residency and neuroimmunology fellowship at the University of Colorado. His research interests include improving the differentiation of autoimmune and infectious encephalitis through clinical features, evaluation of biomarkers of disease activity in autoimmune encephalitis, and evaluation of neuro-rheumatologic diseases such as neuropsychiatric lupus, with a goal of improving diagnosis, prevention, and treatment of these rare diseases. He is also researching neuropsychological and socioeconomic outcomes in pediatric onset multiple sclerosis and evaluation and treatment of regression in patients with Down syndrome.

CU Profile

Google Scholar

Mallory Lowe, MD is an Assistant Professor of Neurology with dual roles as an autoimmune neurologist and as a neurohospitalist. Dr. Lowe completed her neurology residency and a fellowship in neuroinfectious diseases and autoimmune neurology at the University of Colorado. Her clinical interests focus on neuroinflammatory disorders, including autoimmune encephalitis, infectious diseases, and neurorheumatologic conditions. Her research interests are centered on quality improvement and healthcare utilization in patients with rare diseases, as well as the acute diagnostic evaluation and management of neuroinflammatory conditions.

CU Profile

Amanda Piquet, MD is a Professor of Neurology. She is Director of the Autoimmune Neurology Program and holds the Céline Dion Foundation Endowed Chair in Autoimmune Neurology. Dr. Piquet serves as Associate Program Director for the Neuro-Infectious Diseases / Autoimmune Neurology Fellowship Program. Dr. Piquet completed her residency training at the Harvard Medical School’s program at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. After residency, she completed a fellowship in autoimmune neurology at the University of Utah. Her research and clinical interests include autoimmune and infectious encephalitis, neuro-rheumatology, and stiff person syndrome, among others. She is involved with quality improvement projects focused on the diagnosis and management of patients with acute encephalitis and developing biomarkers to better characterize clinical outcomes for patients with autoimmune neurological diseases.

CU Profile

Google Scholar

Teri Schreiner, MD/MPH is a Professor of Neurology and Pediatrics and currently serves as Program Director for the Child Neurology Residency. Dr. Schreiner received a BA in Anthropology from the University of Pennsylvania and an MPH from Yale University before spending several years as a healthcare consultant. She then attended medical school at the University of Rochester before completing her child neurology residency and neuroimmunology fellowship at the University of Colorado. She has interests in multiple sclerosis and neuroinfectious disease and was closely involved in the acute flaccid myelitis (AFM) cluster of cases that presented in the context of an Enterovirus D68 outbreak in 2014. Recent research efforts have included characterizing the 12 month outcomes of the children affected with AFM in 2014. She has lectured nationally on this topic and served as an international resource for providers with similar patients.

CU Profile

Anna Shah, MD is an Assistant Professor of Neurology. Dr. Shah serves as Associate Medical Director and Director of Patient Safety and Experience for the neurology practice at the University of Colorado Hospital. Dr. Shah attended the University of Missouri - Kansas City for her undergraduate studies and medical school. She went on to complete neurology residency at the University of Michigan, where she served as chief resident in her final year. She completed her fellowship in neuroimmunology at the University of Colorado. She sees patients with multiple sclerosis and other related disorders of the nervous system. She has special interests in family planning and women's health in relation to multiple sclerosis and disease-modifying therapies.

CU Profile

Andrew Wolf, MD, is an Assistant Professor of Neurology at the University of Colorado School of Medicine, where he practices as a neurohospitalist and neuroimmunologist. Dr. Wolf completed neurology residency and chief residency followed by a fellowship in neuroimmunology at the the University of Colorado. He sees clinic patients at the Rocky Mountain MS Center at the University of Colorado Hospital and at Denver Health. His research interests center on biomarkers for multiple sclerosis and related neuroinflammatory disorders (including NMOSD and MOGAD) and infectious complications of immunosuppressive therapies. He has authored more than 25 peer-reviewed publications and serves as an investigator on multiple multicenter clinical trials. An active educator and mentor, he is Associate Program Director for the Neuroimmunology Fellowship and also directs the neurology residency program's journal club. His teaching has been recognized with the departmental awards for both medical student and resident education. Dr. Wolf also serves as a founding board member of the Autoimmune Neurology Research Consortium.

CU Profile

Google Scholar

Research Faculty

Kavita V. Nair, PhD is a Professor of Neurology and Pharmacy, holding dual appointments within the Department of Neurology in the School of Medicine and the Department of Clinical Pharmacy in the Skaggs School of Pharmacy and Pharmaceutical Sciences. Her academic journey began with an undergraduate degree in pharmacy from the University of Delhi, followed by a PhD in pharmaceutical outcomes research from the University of Michigan.

As a health outcomes researcher, Dr. Nair has made significant contributions to real-world outcomes research initiatives at the University of Colorado Anschutz Medical Campus. Her work primarily focuses on the comparative effectiveness of drug treatments for neurological diseases, including multiple sclerosis, neuromyelitis optica spectrum disorder, and myasthenia gravis. More recently, she has been exploring treatment pathways for mild cognitive impairment in Alzheimer’s disease.

In addition to her research, Dr. Nair holds several leadership roles within the American Academy of Neurology. Notably, she serves as the Chair of the Coding and Payment Policy Subcommittee, which is the sole subcommittee that liaises between national payers and the American Academy of Neurology. Her advocacy efforts in Colorado have also led to the creation of reform-based policies that enhance patient access to neurological drugs.

CU Profile

Google Scholar

Tools & Resources

CU Campuses

CU Anschutz

Neuroimmunology Section

Department of Neurology, School of Medicine

Faculty

Physicians

Research Faculty

Advanced Practice Providers

Faculty

Physicians

Enrique Alvarez, MD/PhD

Jeffrey Bennett, MD/PhD

John Corboy, MD

Matthew Doerfler, MD

Robert Gross, MD

Ryan Kammeyer, MD

Mallory Lowe, MD

Amanda Piquet, MD

Teri Schreiner, MD

Anna Shah, MD

Elle Wade, MD

Andrew Wolf, MD

Research Faculty

Kavita Nair, PhD

Gregory Owens, PhD

Soumya Yanamuri, PhD

Advanced Practice Providers

Therese Wade, NP

Grace Worland, NP